Personalized Treatment With Emerging BTK Inhibitor Options in CLL/SLL and MCL PeerView Oncology 1:02:27 2 years ago 200 Скачать Далее
New Standards for CLL Care With BTK Inhibitors PeerView Oncology 1:36:53 3 years ago 386 Скачать Далее
Moving towards personalized therapy in CLL & sequencing BTK inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 1:09 1 year ago 104 Скачать Далее
Optimizing Treatment Pathways in CLL and MCL: Evaluating and Applying Recent Data on BTK Inhibitors Medscape 36:55 1 month ago 7 Скачать Далее
Chronic Lymphocytic Leukemia & Small Lymphocytic Lymphoma Leukemia Research Foundation 21:45 3 years ago 1 655 Скачать Далее
BTK Inhibitors for CLL and MCL: What the Latest Data Mean for Our Patients Medscape 49:28 1 month ago 2 Скачать Далее
What is your preferred BTK inhibitor in CLL? OncBrothers: Practice-Changing Cancer Discussions 0:58 6 months ago 193 Скачать Далее
BTK Inhibitors in CLL: Evidence-Informed Therapy Selection, Safety, and Sequential Care PeerView Oncology 1:29:05 2 years ago 185 Скачать Далее
Upgrading the Sequential Therapy Tool Kit for B-Cell Malignancies PeerView Oncology 1:09:38 2 years ago 131 Скачать Далее
Customizing Care in CLL With BTK Inhibitors VJHemOnc – Video Journal of Hematology & HemOnc 4:44 2 years ago 245 Скачать Далее
Treatments for Chronic Lymphocytic Leukemia (CLL) After BTK Inhibitor - Dr. Meghan Thompson ASH 2022 CLL Society 11:27 8 months ago 450 Скачать Далее
Treatment options for patients with CLL who progress after BTK inhibitor therapy VJHemOnc – Video Journal of Hematology & HemOnc 0:58 2 years ago 71 Скачать Далее
